Manufacturers of regenerative medicine products will get a welcome boost from US FDA under the 21st Century Cures Act, says Michael Werner, executive director of trade group the Alliance for Regenerative Medicine
Several clauses within the legislation, which was approved by the House on Nov. 30 and is expected to...






